Reneo Pharmaceuticals, Inc. (37)

Browse by Contract Category

Contracts

Reneo Pharmaceuticals, Inc. Severance Benefit Plan, as amended as of September 27, 2022, and form of Participation Agreement thereunder (Filed With SEC on November 8, 2022)
Letter Agreement by and between the Registrant and Roshawn Blunt, dated August 2, 2022 (Filed With SEC on August 9, 2022)
Description of Common Stock of the Registrant (Filed With SEC on March 23, 2022)
License Agreement by and between the Registrant and vTv Therapeutics LLC, dated December 21, 2017 (Filed With SEC on March 19, 2021)
Transition, Separation and Consulting Agreement by and between the Registrant and Vineet R. Jindal, dated February 2, 2022 (Filed With SEC on March 23, 2022)
Letter Agreement by and between Registrant and Paul W. Hoelscher, dated January 20, 2022 (Filed With SEC on March 23, 2022)
Transition, Separation and Consulting Agreement by and between the Registrant and Wendy Johnson, dated December 23, 2021 (Filed With SEC on March 23, 2022)
Reneo Pharmaceuticals, Inc. 2021 Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 23, 2022)
Reneo Pharmaceuticals, Inc. Severance Benefit Plan, as amended, and form of Participation Agreement thereunder (Filed With SEC on November 12, 2021)
Employment Agreement by and between the Registrant and Ashley F. Hall, J.D., dated October 11, 2021 (Filed With SEC on November 12, 2021)
Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise for Inducement Grant Outside of the Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 12, 2021)
Reneo Pharmaceuticals, Inc. UK Sharesave Sub-Plan to the Reneo Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on November 12, 2021)
Forms of RSU Award Grant Notice and Award Agreement (RSU Award) for Inducement Grant Outside of the Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 12, 2021)
Forms of (i) Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise and (ii) Stock Option Grant Notice - International, Stock Option Agreement - International... (Filed With SEC on April 5, 2021)
Employment Agreement by and between the Registrant and Vineet R. Jindal, dated March 16, 2021 (Filed With SEC on April 5, 2021)
Reneo Pharmaceuticals, Inc. Severance Benefit Plan and form of Participation Agreement thereunder (Filed With SEC on April 5, 2021)
Reneo Pharmaceuticals, Inc. 2021 Non-Employee Director Compensation Policy (Filed With SEC on April 5, 2021)
Reneo Pharmaceuticals, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on April 5, 2021)
Forms of (i) Restricted Stock Unit Award Grant Notice and Award Agreement and (ii) Restricted Stock Unit Award Grant Notice - International and Award Agreement - International... (Filed With SEC on April 5, 2021)
Reneo Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Filed With SEC on April 5, 2021)
Form of Common Stock Certificate (Filed With SEC on April 5, 2021)
Form of Underwriting Agreement (Filed With SEC on April 5, 2021)
Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on April 5, 2021)
Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on March 19, 2021)
Employment Agreement by and between the Registrant and Wendy Johnson, dated February 1, 2018 (Filed With SEC on March 19, 2021)
Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on March 19, 2021)
Form of Indemnity Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on March 19, 2021)
Reneo Pharmaceuticals, Inc. Severance Benefit Plan and form of Participation Agreement thereunder (Filed With SEC on March 19, 2021)
Employment Agreement by and between the Registrant and Gregory J. Flesher, dated November 2, 2020 (Filed With SEC on March 19, 2021)
Letter Agreement by and between the Registrant and Niall ODonnell, Ph.D., dated February 1, 2018 (Filed With SEC on March 19, 2021)
Employment Agreement by and between the Registrant and Michael Cruse, dated November 20, 2020 (Filed With SEC on March 19, 2021)
Employment Agreement by and between the Registrant and Alejandro Dorenbaum, M.D., dated January 1, 2018 (Filed With SEC on March 19, 2021)
Employment Agreement by and between the Registrant and Vineet R. Jindal, dated March 19, 2021 (Filed With SEC on March 19, 2021)
Letter Agreement by and between the Registrant and Michael Grey, dated February 12, 2018, as amended on December 7, 2020 (Filed With SEC on March 19, 2021)
Letter Agreement by and between the Registrant and Lon Cardon, Ph.D., dated January 30, 2019 (Filed With SEC on March 19, 2021)
Letter Agreement by and between the Registrant and Eric M. Dube, Ph.D., dated March 10, 2021 (Filed With SEC on March 19, 2021)
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated December 9, 2020 (Filed With SEC on March 19, 2021)